Tikvah Management LLC, which owns approximately 1.5% of Quanterix Corp.'s outstanding common shares, announced on March 24, 2025, its intention to vote AGAINST the company’s proposed merger with Akoya Biosciences, Inc. This decision aligns with public comments made by other investors opposing the merger.
Tikvah Management believes the proposed transaction is not in the best interest of Quanterix’s shareholders. Their concerns include that the proposed transaction undervalues Quanterix’s shares and would lead to a significant reduction in the Company’s cash runway post-merger.
The firm also stated its belief that Quanterix’s business is superior to Akoya’s. This additional shareholder opposition further complicates the path to completion for the proposed merger, indicating growing investor skepticism regarding the deal's value proposition.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.